Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05198453
NCT05198453CompletedNot Applicable

The Impact of Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19

University Medical Centre Ljubljana1 site in 1 country529 target enrollmentStarted: August 16, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
529
Locations
1
Primary Endpoint
number (%) with critically severe disease
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this study was to evaluate the association between vaccination with one of the four SARS-CoV-2 vaccines authorized for use in the European Union-BNT162b2, ChAdOx-1S, mRNA-1273 or Ad.26.COV2.S-and progression to critically severe disease among adult patients with PCR-confirmed acute COVID-19.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age 18 yers or more
  • •hospitalized for acute COVID-19
  • •PCR confirmed infection with SARS-CoV-2

Exclusion Criteria

  • •hospitalized for other conditions

Outcomes

Primary Outcomes

number (%) with critically severe disease

Time Frame: assessment performed at a minimum 30 days after admission

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daša Stupica

Principal Investigator

University Medical Centre Ljubljana

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
COVID-19 Vaccine Response in Treated MS PatientsHealthyMultiple Sclerosis
NCT05060354Brigham and Women's Hospital159
Completed
Not Applicable
COVID-19 Vaccination AZV 2021-2023COVID-19VaccinationImmunityRespiratory Failure
NCT05589233University Hospital Hradec Kralove3,000
Recruiting
Not Applicable
COVID-19 Vaccine Efficacy in Patients With Malignant PathologiesSolid TumorHematologic MalignancyThoracic CancerCancer, Treatment-RelatedVaccine Response Impaired
NCT04776005Assistance Publique - Hôpitaux de Paris500
Completed
Not Applicable
COVID Booster in Pregnancy and LactationCOVID-19
NCT05543993Thomas Jefferson University150
Completed
Not Applicable
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 VaccineSARS-CoV-2
NCT05894525ModernaTX, Inc.8,844